Medical Procedure News

RSS

Phase II clinical trial to test safety and efficacy of transplanted encapsulated islets

The Juvenile Diabetes Research Foundation announced today that it is partnering with Living Cell Technologies, a New Zealand-based biotechnology company focused on developing cell based therapeutics, in a Phase II clinical trial to study the safety and effectiveness of transplanting encapsulated insulin-producing cells from pigs as a treatment for type 1 diabetes with significant hypoglycemia unawareness.

28 Apr 2010

SI-BONE to present iFuse MIS procedure at WCMISST 2010

SI-BONE, Inc., a medical device company that is pioneering the use of a minimally invasive surgical device to treat the sacroiliac joint today announced that iFuse initial post-market clinical experience will be presented at upcoming 2010 minimally invasive spine surgery meetings.

28 Apr 2010

CNN: Hospital markup on supplies can be big

CNN: "When Dr. Linda Galloway learned she needed surgery to save her vision, she scheduled the procedure immediately with her opthamologist. And what an eye-opener it was - when the hospital bill arrived."

28 Apr 2010

TYRX receives FDA marketing clearance for AIGISRx ST antibacterial patch for soft tissue repair

TYRX, Inc. announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market AIGISRx® ST, its antibacterial product for the surgical repair of damaged or ruptured soft tissue.

28 Apr 2010

CSI granted FDA unconditional IDE approval for trial of Diamondback 360 System in coronary arteries

Cardiovascular Systems, Inc., has received Food and Drug Administration unconditional Investigational Device Exemption (IDE) approval, allowing the company to proceed with ORBIT II, a pivotal trial to evaluate the safety and effectiveness of CSI's Diamondback 360® System in the coronary arteries. CSI received conditional IDE approval for the ORBIT II study in January 2010.

28 Apr 2010

A bitter pill to swallow

Reporting for Kaiser Health News in collaboration with The Washington Post, Sandra Boodman writes: "When Jere Carpentier learned last year that she had advanced colon cancer -- her third malignancy in a dozen years -- she worried about spending hours in a clinic tethered to an intravenous line, enduring punishing chemotherapy that would make her hair fall out.

28 Apr 2010

Alnylam Pharmaceuticals publishes encouraging results from Phase II GEMINI study in PNAS

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has published results from its Phase II GEMINI study in the Proceedings of the National Academy of Sciences (PNAS). These data, previously presented at the International Symposium on Respiratory Viral Infections in Singapore in 2008, showed human proof of concept with an RNAi therapeutic in a randomized, double blind, placebo-controlled study.

27 Apr 2010

Melanin-covered nanoparticles may protect bone marrow from harmful radiation therapy effects: Research

Tiny, melanin-covered nanoparticles may protect bone marrow from the harmful effects of radiation therapy, according to scientists at Albert Einstein College of Medicine of Yeshiva University who successfully tested the strategy in mouse models.

27 Apr 2010

Vital stem cells extracted during heart bypass surgery can help repair damaged heart muscle: BHF

Scientists have for the first time succeeded in extracting vital stem cells from sections of vein removed for heart bypass surgery. Researchers funded by the British Heart Foundation found that these stem cells can stimulate new blood vessels to grow, which could potentially help repair damaged heart muscle after a heart attack.

27 Apr 2010

Jefferson Medical College surgeon uses artificial liver assist device as bridge to transplantation

Cataldo Doria, M.D., Ph.D., Nicoletti Family Professor of Transplant Surgery at Jefferson Medical College of Thomas Jefferson University, and director of the Division of Transplantation at Thomas Jefferson University Hospital is the first transplant surgeon in the United States to use a new totally artificial liver assist device as a bridge to transplantation.

27 Apr 2010

Study suggests way to predict tumors most likely to respond to chemotherapy and radiation

Levels of a key type of immune cell are higher in head and neck cancer patients whose tumors are linked to the human papillomavirus, or HPV, according to researchers at the University of Michigan Comprehensive Cancer Center.

27 Apr 2010

GORE VIABIL Biliary Endoprosthesis receives European CE Mark approval for expanded indication

W. L. Gore & Associates (Gore) today announced it has received European CE Mark approval for an expanded indication of the GORE® VIABIL® Biliary Endoprosthesis that allows removal of the device up to 12 months after implantation for the treatment of benign or malignant biliary strictures. The GORE® VIABIL® Biliary Endoprosthesis first received CE Mark approval in December 1999 and U.S. Food and Drug Administration (FDA) approval in January 2002 for the treatment of biliary strictures due to malignant neoplasms.

27 Apr 2010

VertiFlex enrolls 100 patients in Superion Interspinous Spacer IDE clinical trial

VertiFlex, Inc., a leading innovator of minimally invasive and motion preserving spinal surgery technologies, today announced that 100 patients have been enrolled in its pivotal IDE clinical trial of the Superion Interspinous Spacer (ISS).

27 Apr 2010

Comprehensive book on reconstructive techniques for degenerative mitral valve disease

Elsevier, the world-leading publisher of scientific, technical and medical information products and services, proudly announces the release of a brand-new single volume comprehensive book on reconstructive techniques for degenerative mitral valve disease by the internationally renowned cardiac surgeon and educator, Dr. Alain Carpentier. The book will launch at the 90th Annual Meeting of the American Association for Thoracic Surgery at the Metro Toronto Convention Centre in Toronto, Ontario, Canada, May 1 - 5, 2010.

26 Apr 2010

Thoratec to sell ITC division to Danaher

Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it has signed a definitive agreement to sell its International Technidyne Corporation (ITC) division to Danaher Corporation ( DHR).

From Danaher 26 Apr 2010

Medtronic receives FDA 510(K) clearance for PoleStar N30 Surgical MRI system

Medtronic today announced U.S. Food and Drug Administration (FDA) 510(K) clearance and U.S. launch of the PoleStar® N30 Surgical MRI system, the latest in neuro oncology surgical solutions.

26 Apr 2010

ev3 completes enrollment in study of EverFlex Self-Expanding Stent System for SFA

ev3 Inc. today announced the completion of patient enrollment in the DURABILITY II trial, a prospective, multi-center, single-arm study evaluating the EverFlex® Self-Expanding Stent System for the treatment of superficial femoral artery (SFA) and proximal popliteal lesions. The DURABILITY II study will support a planned Premarket Approval (PMA) filing with the U.S. Food and Drug Administration to obtain approval of the EverFlex Self-Expanding Stent System for use in the SFA.

26 Apr 2010

Reconstructive techniques for degenerative mitral valve disease

26 Apr 2010

Delaying puberty can give transgenders time to decide about gender identity

Complications from transgender procedures may be significantly minimized when treatment of a patient with severe gender identity disorder begins prior to puberty, according to expert opinion today at the American Association of Clinical Endocrinologists (AACE) 19th Annual Meeting & Clinical Congress.

26 Apr 2010

Sexual addiction therapists Steffens Counseling and Hope Source Counseling form strategic partnership

Sexual addiction is defined as any sexually-related, compulsive behavior which interferes with normal living and causes severe stress on family, friends, loved ones, and one's work environment. Sex becomes the organizing principle of an addict's life to the extent they are willing to sacrifice what they cherish most in order to preserve and continue their unhealthy behavior.

26 Apr 2010

Medical Procedure News

Phase II clinical trial to test safety and efficacy of transplanted encapsulated islets

SI-BONE to present iFuse MIS procedure at WCMISST 2010

CNN: Hospital markup on supplies can be big

TYRX receives FDA marketing clearance for AIGISRx ST antibacterial patch for soft tissue repair

CSI granted FDA unconditional IDE approval for trial of Diamondback 360 System in coronary arteries

A bitter pill to swallow

Alnylam Pharmaceuticals publishes encouraging results from Phase II GEMINI study in PNAS

Melanin-covered nanoparticles may protect bone marrow from harmful radiation therapy effects: Research

Vital stem cells extracted during heart bypass surgery can help repair damaged heart muscle: BHF

Jefferson Medical College surgeon uses artificial liver assist device as bridge to transplantation

Study suggests way to predict tumors most likely to respond to chemotherapy and radiation

GORE VIABIL Biliary Endoprosthesis receives European CE Mark approval for expanded indication

VertiFlex enrolls 100 patients in Superion Interspinous Spacer IDE clinical trial

Comprehensive book on reconstructive techniques for degenerative mitral valve disease

Thoratec to sell ITC division to Danaher

Medtronic receives FDA 510(K) clearance for PoleStar N30 Surgical MRI system

ev3 completes enrollment in study of EverFlex Self-Expanding Stent System for SFA

Reconstructive techniques for degenerative mitral valve disease

Delaying puberty can give transgenders time to decide about gender identity

Sexual addiction therapists Steffens Counseling and Hope Source Counseling form strategic partnership

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News